Treatment of elderly onset (EOPsA) and younger onset (YOPsA) psoriatic arthritis at two years
| Treatment | EOPsA, (n) (%) (n=16) | YOPsA, (n) (%) (n=50) | p |
|---|---|---|---|
| Second line drugs | 15 (93.7) | 42 (84) | NS |
| Hydroxychloroquine | 5 (31.2) | 10 (20) | NS |
| Gold salts | 2 (12.5) | 5 (10) | NS |
| Sulphasalazine | 2 (12.5) | 15 (30) | NS |
| Methotrexate | 6 (37.5) | 10 (20) | NS |
| Cyclosporin | 0 | 2 (4) | NS |
| Prednisone >5 mg/day | 7 (43.7) | 5 (10) | NS |
| Mg/prednisone/day | 7.3 (2.2) | 2.3 (1.8) | <0.001 |
For significance at 0.05 level, with six comparisons, Bonferroni adjustment requires a p value of ⩽0.05/8=0.006. Data shown as mean (SD).